Polymeric nanoparticles (PNPs) for oral delivery of insulin

J Nanobiotechnology. 2024 Jan 3;22(1):1. doi: 10.1186/s12951-023-02253-y.

Abstract

Successful oral insulin administration can considerably enhance the quality of life (QOL) of diabetes patients who must frequently take insulin injections. Oral insulin administration, on the other hand, is seriously hampered by gastrointestinal enzymes, wide pH range, mucus and mucosal layers, which limit insulin oral bioavailability to ≤ 2%. Therefore, a large number of technological solutions have been proposed to increase the oral bioavailability of insulin, in which polymeric nanoparticles (PNPs) are highly promising for oral insulin delivery. The recently published research articles chosen for this review are based on applications of PNPs with strong future potential in oral insulin delivery, and do not cover all related work. In this review, we will summarize the controlled release mechanisms of oral insulin delivery, latest oral insulin delivery applications of PNPs nanocarrier, challenges and prospect. This review will serve as a guide to the future investigators who wish to engineer and study PNPs as oral insulin delivery systems.

Keywords: Controlled release; Diabetic; Insulin; Oral delivery; Polymeric nanoparticles (PNPs).

Publication types

  • Review

MeSH terms

  • Administration, Oral
  • Drug Carriers
  • Drug Delivery Systems / methods
  • Humans
  • Insulin*
  • Nanoparticles*
  • Polymers
  • Quality of Life

Substances

  • Insulin
  • Polymers
  • Drug Carriers